Geron Corp (NASDAQ:GERN)
| 1.44 BATS BZX Real-Time Price As of May 13 |  0.00 / 0.00%Today’s Change | 0.99 Today|||52-Week Range 2.23 | +18.03% Year-to-Date |
Latest GERN News | Press Releases
| Why Geron Stock Is Soaring Today May 10 / MotleyFool.com - Paid Partner Content | Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
| Geron (GERN) Q1 2022 Earnings Call Transcript May 10 / MotleyFool.com - Paid Partner Content | Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates May 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.44 |
| Today’s open | 1.47 |
| Day’s range | 1.43 - 1.52 |
| Volume | 93,095 |
| Average volume (3 months) | 2,335,295 |
| Market cap | $547.3M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | -10.29% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +450.59% |
| P/E ratio | NM |
| Price/Sales | 286.94 |
| Price/Book | 3.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SIGASIGA Technologies In... | 0.00 | 0.00% |
| SRNESorrento Therapeutic... | 0.00 | 0.00% |
| BCYCBicycle Therapeutics... | 0.00 | 0.00% |
| ATRAAtara Biotherapeutic... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/13/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$116.1M |
| Net profit margin | -8,335.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
